Vaxart Inc. (United States) is listed on the Nasdaq and has a market capitalization of $99.22 million, with shareholders equity totaling $82.37 million.
The company employs approximately 65 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Vaxart Inc. reported $243.06 million in revenue, generating net income of $38.60 million.
Key financial metrics include a P/E ratio of 2.57, a price-to-book (P/B) ratio of 1.20, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker VXRT.